Logo image of CLMT

CALUMET INC (CLMT) Stock Fundamental Analysis

NASDAQ:CLMT - Nasdaq - US1314281049 - Common Stock - Currency: USD

16.87  -0.27 (-1.58%)

After market: 16.87 0 (0%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to CLMT. CLMT was compared to 210 industry peers in the Oil, Gas & Consumable Fuels industry. CLMT may be in some trouble as it scores bad on both profitability and health. CLMT is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

CLMT had negative earnings in the past year.
CLMT had a negative operating cash flow in the past year.
CLMT had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: CLMT reported negative operating cash flow in multiple years.
CLMT Yearly Net Income VS EBIT VS OCF VS FCFCLMT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

CLMT has a worse Return On Assets (-13.60%) than 88.10% of its industry peers.
Industry RankSector Rank
ROA -13.6%
ROE N/A
ROIC N/A
ROA(3y)-4.08%
ROA(5y)-6.46%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CLMT Yearly ROA, ROE, ROICCLMT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100

1.3 Margins

In the last couple of years the Operating Margin of CLMT has declined.
CLMT has a worse Gross Margin (2.88%) than 76.67% of its industry peers.
CLMT's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for CLMT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 2.88%
OM growth 3YN/A
OM growth 5Y-41.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.67%
GM growth 5Y-15.88%
CLMT Yearly Profit, Operating, Gross MarginsCLMT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

More info and screens

1

2. Health

2.1 Basic Checks

CLMT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CLMT has been increased compared to 1 year ago.
CLMT has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CLMT is higher compared to a year ago.
CLMT Yearly Shares OutstandingCLMT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CLMT Yearly Total Debt VS Total AssetsCLMT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

Based on the Altman-Z score of 1.13, we must say that CLMT is in the distress zone and has some risk of bankruptcy.
CLMT has a Altman-Z score (1.13) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.13
ROIC/WACCN/A
WACC10.92%
CLMT Yearly LT Debt VS Equity VS FCFCLMT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B 2B

2.3 Liquidity

CLMT has a Current Ratio of 1.06. This is a normal value and indicates that CLMT is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of CLMT (1.06) is comparable to the rest of the industry.
A Quick Ratio of 0.61 indicates that CLMT may have some problems paying its short term obligations.
CLMT has a worse Quick ratio (0.61) than 74.76% of its industry peers.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.61
CLMT Yearly Current Assets VS Current LiabilitesCLMT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

4

3. Growth

3.1 Past

The earnings per share for CLMT have decreased strongly by -6642.86% in the last year.
Looking at the last year, CLMT shows a very strong growth in Revenue. The Revenue has grown by 24.90%.
CLMT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.94% yearly.
EPS 1Y (TTM)-6642.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-407.84%
Revenue 1Y (TTM)24.9%
Revenue growth 3Y9.99%
Revenue growth 5Y3.94%
Sales Q2Q%-1.18%

3.2 Future

Based on estimates for the next years, CLMT will show a very strong growth in Earnings Per Share. The EPS will grow by 29.17% on average per year.
The Revenue is expected to grow by 7.25% on average over the next years.
EPS Next Y-0.07%
EPS Next 2Y42.12%
EPS Next 3Y28.42%
EPS Next 5Y29.17%
Revenue Next Year-3.8%
Revenue Next 2Y-2.77%
Revenue Next 3Y1.23%
Revenue Next 5Y7.25%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CLMT Yearly Revenue VS EstimatesCLMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B
CLMT Yearly EPS VS EstimatesCLMT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 4 -4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

CLMT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 321.59, which means the current valuation is very expensive for CLMT.
70.95% of the companies in the same industry are cheaper than CLMT, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of CLMT to the average of the S&P500 Index (37.64), we can say CLMT is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 321.59
CLMT Price Earnings VS Forward Price EarningsCLMT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200 300

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CLMT is valued a bit more expensive than 74.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 83.54
CLMT Per share dataCLMT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

A more expensive valuation may be justified as CLMT's earnings are expected to grow with 28.42% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.12%
EPS Next 3Y28.42%

More info and screens

0

5. Dividend

5.1 Amount

CLMT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CALUMET INC

NASDAQ:CLMT (7/25/2025, 8:00:00 PM)

After market: 16.87 0 (0%)

16.87

-0.27 (-1.58%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-09 2025-05-09/bmo
Earnings (Next)08-08 2025-08-08
Inst Owners46.21%
Inst Owner Change0.37%
Ins Owners3.14%
Ins Owner Change-0.04%
Market Cap1.46B
Analysts78.46
Price Target20.4 (20.92%)
Short Float %13.99%
Short Ratio7.98
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-158.08%
Min EPS beat(2)-346.52%
Max EPS beat(2)30.36%
EPS beat(4)2
Avg EPS beat(4)-89.27%
Min EPS beat(4)-346.52%
Max EPS beat(4)30.36%
EPS beat(8)4
Avg EPS beat(8)76.92%
EPS beat(12)5
Avg EPS beat(12)-483.8%
EPS beat(16)7
Avg EPS beat(16)-347.91%
Revenue beat(2)2
Avg Revenue beat(2)5.15%
Min Revenue beat(2)0.99%
Max Revenue beat(2)9.31%
Revenue beat(4)4
Avg Revenue beat(4)8.63%
Min Revenue beat(4)0.99%
Max Revenue beat(4)13.26%
Revenue beat(8)7
Avg Revenue beat(8)7.42%
Revenue beat(12)11
Avg Revenue beat(12)9.08%
Revenue beat(16)15
Avg Revenue beat(16)11.52%
PT rev (1m)0%
PT rev (3m)-2.44%
EPS NQ rev (1m)-5.88%
EPS NQ rev (3m)-22.45%
EPS NY rev (1m)-13.97%
EPS NY rev (3m)-120.99%
Revenue NQ rev (1m)-4.89%
Revenue NQ rev (3m)-3.27%
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)5.53%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 321.59
P/S 0.28
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 83.54
EPS(TTM)-4.72
EYN/A
EPS(NY)0.05
Fwd EY0.31%
FCF(TTM)-1.59
FCFYN/A
OCF(TTM)-0.73
OCFYN/A
SpS59.84
BVpS-9.95
TBVpS-9.95
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.6%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 2.88%
FCFM N/A
ROA(3y)-4.08%
ROA(5y)-6.46%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.9%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-41.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.67%
GM growth 5Y-15.88%
F-Score3
Asset Turnover1.84
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 47.76
Cap/Depr 49.87%
Cap/Sales 1.43%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 0.61
Altman-Z 1.13
F-Score3
WACC10.92%
ROIC/WACCN/A
Cap/Depr(3y)260.7%
Cap/Depr(5y)180.19%
Cap/Sales(3y)6.59%
Cap/Sales(5y)4.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-6642.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-407.84%
EPS Next Y-0.07%
EPS Next 2Y42.12%
EPS Next 3Y28.42%
EPS Next 5Y29.17%
Revenue 1Y (TTM)24.9%
Revenue growth 3Y9.99%
Revenue growth 5Y3.94%
Sales Q2Q%-1.18%
Revenue Next Year-3.8%
Revenue Next 2Y-2.77%
Revenue Next 3Y1.23%
Revenue Next 5Y7.25%
EBIT growth 1Y-138.21%
EBIT growth 3YN/A
EBIT growth 5Y-39.24%
EBIT Next Year3176.38%
EBIT Next 3Y277.46%
EBIT Next 5Y146.58%
FCF growth 1Y73.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-182.03%
OCF growth 3YN/A
OCF growth 5YN/A